Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscyamine vs Tamsulosin for Ureteral Stent Irritation
NCT03750656Phase 4Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- Nov 2018
- Primary completion
- Aug 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscyamine in lower urinary tract symptoms (LUTS), sponsored by University of Kansas Medical Center. Started Nov 2018; status: terminated.
02
Drugs
hyoscyamine
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT03750656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03750656.